NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of raw human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.
Company Growth (employees)
Type
Private
HQ
Palo Alto, US
Founded
2008
Size (employees)
9 (est)
NuMedii was founded in 2008 and is headquartered in Palo Alto, US

Key People/Management at NuMedii

Gini Deshpande

Gini Deshpande

Founder and Chief Executive Officer

NuMedii Office Locations

NuMedii has an office in Palo Alto
Palo Alto, US (HQ)
2479 East Bayshore Road Suite 225 Palo Alto

NuMedii Financials and Metrics

Summary Metrics

Founding Date

2008

Total Funding

$5.5 m

Latest funding size

$2 m

Time since last funding

over 2 years

Investors

NuMedii's latest funding round in August 2015 was reported to be $2 m. In total, NuMedii has raised $5.5 m

NuMedii's Web-traffic and Trends

NuMedii Online and Social Media Presence

NuMedii Company Life and Culture

You may also be interested in